How a virus transforms immune cells into cancer uncovered by researchers
An international team have mapped how the HTLV-1 virus causes a rare leukaemia in some people, providing clues on how to stop it happening.
Study identifies potential biomarkers for urine test for bile duct cancer
Early-stage research has found 10 metabolites associated with bile duct cancer which might one day help create a urine test to identify the cancer.
Imperial partnered with DNA Electronics to develop breast cancer diagnostic test
Imperial has partnered with healthcare company DNA Electronics (DNAe) to develop a new platform for monitoring breast cancer.
Sept 2021 - Article Published in Nano Today
Stas Piletsky's paper using Molecular Imprinted Polymers (MIPs) to discover epitopes of utility for targeting cancers is published in Nano Today.
Imperial RNA technology to be developed by VaxEquity with AstraZeneca
Imperial startup VaxEquity has announced a strategic, long-term research collaboration with AstraZeneca to develop its self-amplifying RNA technology
Changing impact of COVID-19 on cancer patients and recovery
Two new papers from Imperial researchers have highlighted how the impact of COVID-19 on cancer patients has changed through the pandemic.
A novel study on Tumour Identification During Fluorescence Guided Breast Surgery
A Hamlyn-led project investigated the diagnostic accuracy in detecting tumours during breast conserving surgery by using intravenous indocyanine green
Prostate cancer drugs hold potential for treating COVID-19
Drugs typically used to treat prostate cancer could be explored for treating patients with COVID-19, following encouraging new findings.
Tricky turbulence and lung cancer links: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
AI breast cancer screening project wins government funding for NHS trial
UK researchers have secured government funding to study the use of artificial intelligence for breast cancer screening in NHS hospitals.
